Institut Pasteur de la Guyane: study shows that resistance to malaria treatment is growing in the Amazon

Current therapeutic combinations recommended to treat malaria are based on the molecule artemisinin and some of its derivatives. But the risk that Plasmodium falciparum, the parasite responsible for most cases of malaria, will end up developing widespread resistance to the drug must be taken seriously. Scientists from the Institut Pasteur de la Guyane investigated the impact of a genetic mutation in Plasmodium falciparum on the efficacy of treatments.

Find out more (in French)